Cisplatin radiosensitizes radioresistant human mesenchymal stem cells

Cisplatin-based chemo-radiotherapy is widely used to treat cancers with often severe therapy-associated late toxicities. While mesenchymal stem cells (MSCs) were shown to aid regeneration of cisplatin- or radiation-induced tissue lesions, the effect of the combined treatment on the stem cells remain...

Descripción completa

Detalles Bibliográficos
Autores principales: Rühle, Alexander, Perez, Ramon Lopez, Glowa, Christin, Weber, Klaus-Josef, Ho, Anthony D., Debus, Jürgen, Saffrich, Rainer, Huber, Peter E., Nicolay, Nils H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675674/
https://www.ncbi.nlm.nih.gov/pubmed/29152122
http://dx.doi.org/10.18632/oncotarget.21214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675674/
https://www.ncbi.nlm.nih.gov/pubmed/29152122
http://dx.doi.org/10.18632/oncotarget.21214

Ejemplares similares